ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,154.43
0.11%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Foamix Pharmaceuticals Ltd (FOMX)

  7. Foamix Pharmaceuticals Ltd (FOMX) ニュース

FOMX

Foamix Pharmaceuticals (FOMX)

Foamix Pharmaceuticals Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FOMX
日付受信時刻ニュースソース見出しコード企業名
2020/03/2319 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/2004 : 10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1905 : 34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1905 : 33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1905 : 33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1905 : 32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1905 : 31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1822 : 53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1220 : 17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1220 : 03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1206 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/1019 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0922 : 27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0407 : 02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0406 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0406 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0406 : 39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0406 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0406 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
2020/03/0406 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:FOMX

最近閲覧した銘柄

BIT
UC7PWZ
Unicredit Bank
GATE
GOVUSDT
SubDAO Governance
HITB
STRATBTC
Stratis
LSE
NFDS
Northern Foods
HUOB
USTUSDT
LSE
CFTA
COIN
BANDEXUST
Banana Index
NYSE
ARC
ARC Document Solutions
USOTC
DTARF
Delta Resources (PK)
TSXV
ARN
TSX
NXE
NexGen Energy
LSE
BW68
Hsbc Bk.25
COIN
PWCBTC
BIT
UB0P2K
UniCredit Bank
KOSPI
570068
True Kosdaq 150 ETN 68
LSE
QCLU
Ft Qclu
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有